ITCI EV/EBITDA
-107.94
-1.04-0.97%
Sat, 18 Jan 2025 00:39:53 GMT
Summary:
As of January 21, 2025, ITCI EV/EBITDA is -107.94, with a fall of -1.04 (-0.97%) during the most recent trading day. Over the past year, it has dropped by -68.75 (-175.43%). ITCI EV/EBITDA is now -5089.42% below its all-time high of -2.08.ITCI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -1.0% |
| 1 m1 month | -47.8% |
| 3 m3 months | -66.3% |
| 6 m6 months | -66.5% |
| ytdytd | -55.5% |
| 1 y1 year | -175.4% |
| 5 y5 years | -913.5% |
ITCI EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -67.68 | -59.5% | -107.94 | at low |
| 3 m | 3-month | -62.40 | -73.0% | -107.94 | at low |
| 6 m | 6-month | -58.33 | -85.0% | -107.94 | at low |
| 1 y | 1-year | -28.43 | -279.7% | -107.94 | at low |
| 3 y | 3-year | -12.38 | -771.9% | -107.94 | at low |
| 5 y | 5-year | -4.75 | -2172.4% | -107.94 | at low |
| alltime | all time | -2.08 | -5089.4% | -107.94 | at low |
Intra-Cellular Therapies EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -107.94(+55.5%) |
| 2024 | -69.40(+61.9%) |
| 2023 | -42.86(+130.6%) |
| 2022 | -18.59(+25.6%) |
| 2021 | -14.80(+35.0%) |
| 2020 | -10.96(-7.5%) |
| Date | Value |
|---|---|
| 2019 | -11.85(+236.6%) |
| 2018 | -3.52(-52.1%) |
| 2017 | -7.35(+41.6%) |
| 2016 | -5.19(-76.0%) |
| 2015 | -21.67(+44.7%) |
| 2014 | -14.98 |
FAQ
- What is Intra-Cellular Therapies EV/EBITDA?
- What is the all time high EV/EBITDA for Intra-Cellular Therapies?
- What is ITCI EV/EBITDA year-to-date change?
- What is Intra-Cellular Therapies EV/EBITDA year-on-year change?
What is Intra-Cellular Therapies EV/EBITDA?
The current EV/EBITDA of ITCI is -107.94
What is the all time high EV/EBITDA for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high EV/EBITDA is -2.08
What is ITCI EV/EBITDA year-to-date change?
Intra-Cellular Therapies EV/EBITDA has changed by -38.54 (-55.53%) since the beginning of the year
What is Intra-Cellular Therapies EV/EBITDA year-on-year change?
Over the past year, ITCI EV/EBITDA has changed by -68.75 (-175.43%)